Literature DB >> 22002647

Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.

Roberta Ara1, John Brazier.   

Abstract

BACKGROUND: There is currently no consensus on the most appropriate method to estimate health state utility values (HSUVs) for comorbid health conditions.
OBJECTIVE: The objective of the study was to assess the accuracy by applying 5 different methods to an EQ-5D dataset.
METHODS: EQ-5D data (n=41,174) from the Health Survey for England were used to compare HSUVs generated using the additive, multiplicative and minimum methods, the adjusted decrement estimator, and a linear regression.
RESULTS: The additive and multiplicative methods underestimated the majority of HSUVs and the magnitude of the errors increased as the actual HSUV increased. Conversely, the minimum and adjusted decrement estimator methods overestimated the majority of HSUVs and the magnitude of errors increased as the actual HSUV decreased. Although the simple linear model produced the most accurate results, there was a tendency to underpredict higher HSUVs and overpredict lower HSUVs. The magnitude and direction of mean errors could be driven by the actual scores being estimated in addition to the technique used and the HSUVs estimated using an adjusted baseline were generally more accurate.
CONCLUSIONS: The additive and minimum methods performed very poorly in our data. Although the simple linear model gave the most accurate results, the model requires validating in external data obtained from the EQ-5D and other preference-based measures. Based on the current evidence base, we would recommend the multiplicative method is used together with a range of univariate sensitivity analyses.

Mesh:

Year:  2012        PMID: 22002647     DOI: 10.1097/MLR.0b013e318234a04a

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  9 in total

1.  Is universal HLA-B*15:02 screening a cost-effective option in an ethnically diverse population? A case study of Malaysia.

Authors:  H Y Chong; Z Mohamed; L L Tan; D B C Wu; F H Shabaruddin; M Dahlui; Y D Apalasamy; S R Snyder; M S Williams; J Hao; L H Cavallari; N Chaiyakunapruk
Journal:  Br J Dermatol       Date:  2017-09-21       Impact factor: 9.302

Review 2.  Estimating Health State Utility Values for Comorbidities.

Authors:  Roberta Ara; John Brazier
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

3.  The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.

Authors:  Eric Jutkowitz; Maureen Dubreuil; Na Lu; Karen M Kuntz; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-11-01       Impact factor: 5.532

4.  Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population.

Authors:  Surasak Saokaew; Wichittra Tassaneeyakul; Ratree Maenthaisong; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

Review 5.  Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review.

Authors:  Manuel B Huber; Margarethe E Wacker; Claus F Vogelmeier; Reiner Leidl
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

6.  Accounting for multimorbidity can affect the estimation of the Burden of Disease: a comparison of approaches.

Authors:  Henk B M Hilderink; Marjanne H D Plasmans; Bianca E P Snijders; Hendriek C Boshuizen; M J J C René Poos; Coen H van Gool
Journal:  Arch Public Health       Date:  2016-08-22

7.  Health-related quality of life in older adults: Effects of hearing loss and common chronic conditions.

Authors:  Annie N Simpson; Kit N Simpson; Judy R Dubno
Journal:  Healthy Aging Res       Date:  2015-02-03

8.  Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India.

Authors:  Dimple Butani; Nidhi Gupta; Gaurav Jyani; Pankaj Bahuguna; Rakesh Kapoor; Shankar Prinja
Journal:  Breast Cancer (Dove Med Press)       Date:  2021-11-27

9.  Predictors of Health-Related Quality of Life After Revision Total Hip Arthroplasty for Aseptic Loosening.

Authors:  Yuichi Kuroda; Shinya Hayashi; Shingo Hashimoto; Tomoyuki Matsumoto; Koji Takayama; Ryosuke Kuroda
Journal:  Indian J Orthop       Date:  2020-03-02       Impact factor: 1.251

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.